Introduction

This page provides a comprehensive analysis of the known insider trading history of Joseph J Manning. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Joseph J Manning has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABT / Abbott Laboratories EXECUTIVE VICE PRESIDENT 62,323
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Joseph J Manning. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Joseph J Manning as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2023-03-02 2023-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,339 62,323 -2.10 100.70 -134,837 6,275,926
2023-03-02 2023-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -5,438 63,662 -7.87 99.77 -542,549 6,351,558
2023-02-22 2023-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 15,855 69,100 29.78
2022-09-09 2022-09-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -23,008 53,245 -30.17 107.00 -2,461,856 5,697,215
2022-09-09 2022-09-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 23,008 76,253 43.21 44.40 1,021,555 3,385,633
2022-08-26 2022-08-25 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -3,890 53,245 -6.81 105.24 -409,384 5,603,504
2022-08-26 2022-08-25 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -23,008 57,135 -28.71 104.99 -2,415,704 5,998,838
2022-08-26 2022-08-25 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 23,008 80,143 40.27 44.40 1,021,555 3,558,349
2022-03-02 2022-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -779 60,873 -1.26 118.16 -92,047 7,192,766
2022-03-02 2022-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -5,850 61,652 -8.67 122.41 -716,098 7,546,821
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 72,342 72,342
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 15,523 67,502 29.86
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -5,974 55,733 -9.68 121.58 -726,319 6,776,018
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 66,658 66,658
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 13,004 61,707 26.70
2021-02-03 2021-02-02 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -3,130 59,681 -4.98 123.03 -385,084 7,342,553
2021-02-03 2021-02-01 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -18,750 18,750 -50.00
2021-02-03 2021-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -18,750 62,811 -22.99 122.79 -2,302,264 7,712,399
2021-02-03 2021-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 18,750 81,561 29.85 38.40 720,000 3,131,942
2020-03-03 2020-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -5,909 62,811 -8.60 79.19 -467,934 4,974,003
2020-03-03 2020-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 4,436 68,720 6.90
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 83,818 83,818
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 13,750 64,284 27.21
2020-01-29 2020-01-27 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -37,500 37,500 -50.00
2020-01-29 2020-01-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -37,500 50,534 -42.60 89.58 -3,359,411 4,527,053
2020-01-29 2020-01-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 37,500 88,032 74.21 38.40 1,440,000 3,380,429
2019-09-04 2019-08-30 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -47,226 0 -100.00
2019-09-04 2019-08-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -47,226 50,532 -48.31 85.14 -4,020,685 4,302,148
2019-09-04 2019-08-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 47,226 97,755 93.46 47.00 2,219,622 4,594,485
2019-03-21 2019-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -5,500 50,529 -9.82 79.58 -437,674 4,020,946
2019-03-21 2019-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -113 56,029 -0.20 79.57 -8,991 4,458,228
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,223 56,142 -2.13 78.00 -95,394 4,379,076
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -3,959 57,365 -6.46 77.23 -305,754 4,430,299
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 7,288 61,324 13.49
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 81,578 81,578
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 15,563 54,036 40.45
2018-03-02 2018-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,430 38,466 -3.58 58.98 -84,344 2,268,802
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -2,786 39,896 -6.53 60.55 -168,692 2,415,703
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 9,520 42,682 28.71 60.55 576,436 2,584,395
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 61,192 61,192
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 11,127 33,162 50.50
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -3,200 0 -100.00
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -600 22,024 -2.65 43.97 -26,384 968,461
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -400 22,624 -1.74 43.97 -17,588 994,800
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -2,300 23,024 -9.08 43.95 -101,078 1,011,836
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -500 25,324 -1.94 43.94 -21,972 1,112,863
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -100 25,824 -0.39 43.94 -4,394 1,134,784
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -100 25,924 -0.38 43.94 -4,394 1,139,126
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -200 26,024 -0.76 43.94 -8,788 1,143,495
2017-04-28 2017-04-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 3,200 26,224 13.90 26.70 85,431 700,110
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1 23,024 0.00 44.96 -45 1,035,182
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -300 23,025 -1.29 44.96 -13,489 1,035,280
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -56 23,325 -0.24 44.96 -2,518 1,048,776
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -387 23,381 -1.63 44.96 -17,401 1,051,296
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -1,463 23,768 -5.80 45.46 -66,508 1,080,493
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 5,085 25,231 25.24 45.46 231,164 1,147,001
2017-02-22 2017-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -146 20,146 -0.72 44.98 -6,567 906,187
2017-02-22 2017-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -287 20,292 -1.39 44.69 -12,826 906,849
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 92,032 92,032
2017-02-07 2017-02-03 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -300 0 -100.00
2017-02-07 2017-02-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -213 20,579 -1.02 42.75 -9,106 879,752
2017-02-07 2017-02-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 300 20,792 1.46 25.25 7,574 524,917
2017-01-25 3 ABT ABBOTT LABORATORIES
Common shares without par value 		40,984
2017-01-25 3 ABT ABBOTT LABORATORIES
Common shares without par value 		40,984
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)